Novavax Inc (NASDAQ:NVAX)

1.66
Delayed Data
As of May 21
 -0.06 / -3.49%
Today’s Change
0.90
Today|||52-Week Range
2.75
+33.87%
Year-to-Date
Weekly CFO Buys Highlight
May 20 / GuruFocus News - Paid Partner Content
Novavax Inc (NVAX) President and CEO Stanley C Erck Bought $165,000 of Shares
May 15 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close1.72
Today’s open1.73
Day’s range1.65 - 1.73
Volume4,607,460
Average volume (3 months)10,000,463
Market cap$645.0M
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)+38.83%
Earnings growth (this year)+16.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+103.06%
P/E ratioNM
Price/Sales11.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.05-1.45%
EDGEEdge Therapeutics In...-0.07-6.75%
BTXBioTime Inc-0.07-2.95%
RIGLRigel Pharmaceutical...-0.09-2.22%
Data as of 8:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$31.2M
Annual profit (last year)-$183.8M
Net profit margin-589.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts